There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders

Creative Commons License

Akman-Karakas A., Yalcin A. D., Koc S., GÜMÜŞLÜ S., Senol Y. Y., Ozkesici B., ...Daha Fazla

MEDICAL SCIENCE MONITOR, cilt.19, ss.888-891, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19
  • Basım Tarihi: 2013
  • Doi Numarası: 10.12659/msm.889624
  • Dergi Adı: MEDICAL SCIENCE MONITOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.888-891
  • Anahtar Kelimeler: autoimmune, inflammatory, skin, soluble CD200 (sCD200), psoriasis, pemphigus, SCD200, OMALIZUMAB, EXPRESSION, IL-1-BETA, PSORIASIS, DELIVERY
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: Soluble CD200 (sCD200) is a novel immuno-effective molecule, which acts to regulate inflammatory and acquired immune responses. Recently, our study group showed that sCD200 was present in serum and blister fluid in a patient with bullous pemphigoid and a patient with toxic epidermal necrolysis. We therefore planned this study to evaluate the sCD200 levels of autoimmune and inflammatory skin disorder patients and to compare them with that of healthy controls.